procedure, we found that the activity decreased from 10.74 U/L to 3.49 U/L, a value that compares with those reported by several laboratories listed in Table 1 . Moreover, when we simultaneously reconstituted the material and dissolved the stabilizer tablet in the vial containing the acid phosphatase control material, we measured an activity of 4.17 U/L, the range of means for separate vials being 3.49 to 4.97 U/L. Using this procedure for a quality-control program, our within-month CVs ranged from 6.7 to 36.9% during five months.
Our pH studies indicate that essentially
all acid phosphatase activity is lost when the human lyophilized control is reconstituted with 0.1 mollL HC1, even though the final pH of the reconstituted control is buffered to a pH of 2.6. The measured pH of the dissolving stabilizer tablets approaches a pH of 2.0, and we reasoned that at this pH the acid phosphatase in the immediate vicinity of the dissolving citric acid tablet could be denatured.
However, when the human-source lyophilized control was reconstituted with a pH 2 HC1 solution, almost no acid phosphatase activity was lost, the value being 97% of that observed with direct citric acid reconstitution.
Evidently there is essentially no denaturation of acid phosphatase at the pH generated by the dissolving citric acid tablets. Thus we attribute the lower acid phosphatase results obtained for the human-source control material, when prepared by the indirect citric acid reconstitution and subsequent tablet addition methods, to activity losses related to inadequate acid stabilization during the reconstitution process. Estimates of imprecision (coefficients of variation) for both Normal and Abnormal controls for the laboratories CLIN. CHEM. 29 /12, 2096-2099 (1983) listed in Table 1 are as high as 70.4% for the Normal control and 34.5% for the Abnormal. As shown in Table 2 , the mean, standard deviation, and CV data collected and compared on a between-month basis showed that the stabilized lyophilized control material of human origin was satisfactory for controlling this assay in the aca for an extended period.
We conclude that lyophilized control material of human origin can be validly used in quality control of acid phosphatase assay after adequate stabilization by direct reconstitution with citric acid, with aliquots being stored frozen.
We thank Mr of binary mixtures of semi-purified human LD isoenzymes (2,3). Analytical recovery of LD-1 and LD-5 obtained from heart and liver tissue (2) and of LD-1 and LD-2 from erythrocytes (3) showed that the technique was free from bias and did appear to measure those LD isoenzymes accurately. We now extend our assessment of the accuracy and precision of this method by using ternary and quaternary mixtures of semi-purified human LD isoenzymes. lsoenzyme Purification LD-1, LD-2, and LD-3 were purified from human erythrocytes as previously described (6, 7) and LD-5 was purified from human liver (8) . After the isoenzymes were resolved on ion-exchange mini-columns, the homogeneity of each preparation was established by thin-layer electrophoresis on agarose (4). Fluorescence densitometry measurements of the LD isoenzymes separated on the gel were recorded with a Clini-Scan densitometer (Helena Laboratories, Beaumont, TX 77704) and the percentage distribution of the isoenzymes were determined both by peak height (amplitude) and by peak area (integration). 
Materials and Methods

Materials
Results
Optimum Conditions for LD Reaction-Rate Assay
The optimum pyruvate concentration for the assay of LD-3 was found to be 1.5 mmol/L. The assigned value for the activity of each isoenzyme was determined by measuring each preparation 20 times, using the appropriate optimum pyruvate concentration in the reaction-rate assay. The CV of this assay ranged between 3 and 5%.
Assigned
Value of LD Isoenzymes
The "true" value (i.e, the assigned value) for each isoenzyme in a mixture was taken as the mean value of the optimized reaction-rate assay. The total LD activity of these mixtures did not exceed 378 U/L-.-our upper reference range for healthy subjects (3); this precaution was necessary to avoid the possibility of substrate depletion (9) .
Precisionof the LD lsoenzyme Assay
All LD isoenzyme assays were accompanied, on the same plate, by a human quality-control serum (10). The mean and SD for each isoenzyme (as percentage of the total LD activity) was LD-1, 22.2 ± 1.06; LD-2, 32.6 ± 1.04; LD-3, 21.6 ± 0.89; LD-4, 10.63 ± 0.83; and LD-5, 12.97 ± 1.14.
The precision of the scanning fluorescence densitometer recording system, measured by repeated scans of a single LI) isoenzyme separation, had SDs of <0.3% (peak heightamplitude) and <0.5% (peak area-integration).
Accuracy of the Estimation of LD lsoenzymes
Before each experiment, the homogeneity of each preparation was checked by means of LD isoenzyme assay. Each mixture contained only the isoenzymes added to it, with no evidence of hybridization.
Representative scans of the ternary mixtures used are shown in Figure 1 . Resolution of the quaternary mixture was equally good. Table 1 lists the results (both within and between analytical batches) we obtained on using a variety of ternary and quaternary mixtures of the LD isoenzymes. The concurrences between the assigned and the recovered values of the mixture are nearly always within one SD of the electrophoretic assay. Changing the proportions of each isoenzyme had little or no effect on the method's apparent accuracy. However, it was clear that the concurrence was better when the isoenzymes were measured by peak area (integration) than by peak height (amplitude), but the spread of values (i.e, the SD) is greater with the former.
Discussion
We have previously shown that binary mixtures of human LD isoenzymes could be measured accurately by our thinlayer agarose electrophoretic technique (2, 3) . With the binary mixture of LD-1:LD-5 we showed that this assay did not have an anodic bias. This bias (i.e., overestimation of LD-1 and underestimation of LD-5) is evident when reference ranges are examined. Many techniques-and it would be invidious to mention any-fail adequately to measure the correct mean proportion of LD-5 in the serum of healthy persons, values of about 5% often being reported. By contrast, with our own validated technique, the mean proportion of LD-5 is about 11%-a twofold difference. Data obtained by using methods with anodic bias cannot readily be transferred into universal experience. This then is the advantage of using techniques that accurately measure the analytes being studied: findings are universally applicable.
The need for accurate methodology is nicely illustrated when the LD-1/LD-2 ratio is considered. This ratio is used to detect the existence of, particularly, hemolysis and myocardial infarction. We have documented (3, 11) the very wide range of reported LD-1ILD-2 ratios for erythrocytes and serum. In the face of these widely differing values it is obvious that experience gained at one center cannot readily be transferred, or utilized, by others. We were able to point out the clinical implications of this lack of method concordance with regard to the influence of hemolysis on the serum LD-1ILD-2 ratio (3). In our own previous work we purified human LD-1 and LD-2 and showed that our techmque accurately measured both LD-1 and LD-2 (3). In the present study we used ternary and quaternary mixtures of LD-1, LD-2, LD-3, and LD-5 to show that our agarose technique can measure all of these isoenzymes accurately. Our earlier work (2,3) could be criticized on the grounds that the accuracy of the method was only tested with binary mixtures and that while the LD-1:LD-5 pair (2) may be measured correctly, this did not necessarily mean that the isoenzymes between them (i.e., LD-2, LD-3, and LD-4) could also be accurately determined. Likewise, when the LD-1:LD-2 pair was measured (3) these findings might not apply to the other isoenzymes, although it is probably reasonable to expect that if LD-1, LD-2, and LD-5 are accurately determined then LD-3 and LD-4 should be too. This present study is directed to those possible deficiencies in our earlier work. We have now shown that LD-3-in a number of different mixtures (e.g., LD-1:LD-2:LD-3, LD-1:LD-3:LD-5, LD-2:LD-3:LD-5, LD-1:LD-2:LD-3:LD-5)-can also be accurately measured. We have omitted LD-4 from the study because of the difficulty of obtaining it in sufficient quantity to use in such studies, but if LD-3 and LD-5 are accurately measured then LD-4 (the isoenzyme with properties midway between LD-3 and LD-5) probably is also.
In the present study we used the Helena Cliniscan Densitometer in two modes: peak height (amplitude) and peak area (integration). We showed ( Table 1 ) that peak area measurements were more accurate but less precise than peak height determinations.
We previously found the Clifford Densitometer to be less precise for peak area measurements (12).
Finally, it is probably necessary to clarify the reason for our use of the term "accuracy." The IFCC Expert Panel on Nomenclature and Principles of Quality Control (13) recommended that a "true value" may be defined as the most probable value derived from a set of results obtained by the most reliable reference method available. It is evident that no reference method (reliable or otherwise) is available either for total U) activity or for LI) isoenzyme activities.
However, the Expert Panel suggest (13) that under these circumstances "assigned values" may be substituted.
In the present study we have determined assigned values for the U) isoenzymes by the use of a well-recognized LD assay (5). Therefore, in the context of our existing methodology, this study is probably the best that can be achieved currently to establish estimates of the accuracy of an LI) isoenzyme assay.
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